DOCTEUR RENAUX DELPHINE
ActiveSummary
The computed 12-month bankruptcy probability of DOCTEUR RENAUX DELPHINE is 2.7% (moderate). The 2025 annual accounts show equity of €99k and a net result of €7k. Equity is growing by ~36.4% per year across the filed fiscal years. The company has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals.
Checked score
Score 2025
60
/ 100
Healthy
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability73▼-10
Solvency70▲+12
Growth52▼-26
Track record94
Bankruptcy probability, 12 months
2.7%
Moderate
0%0.5%1.5%4%10%≥ 25%
Credit up to €5k at 30 days acceptable
Liquidity short (current ratio 0.52 against 0.53 in 2024; short-term debt: 25.3% and cash: 9.5% of total assets), and 54.7% of the assets are financed with debt.
Credit check for your own amount and term
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
45.3%
Return on assets
3.3%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 03-07-2026, 28 days ahead of the deadline.
NBB · 4 filingsDeviation from the deadline
2025
28 d early
2024
31 d early
2023
15 d early
2022
11 d early
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
24-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Turnover
€221k
EBIT margin
22.5%
Net result
€7k▼ 76.6%
2024 · €31k
2022: €20k
2023: €36k
2024: €31k
2022 → 2025
Working capital
€-27k▲ 25.5%
2024 · €-36k
2022: €-100k
2023: €-70k
2024: €-36k
2022 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line2022202320242025Trend
Turnover€221k
Equity€25k-€61k▲ 149%€92k▲ 50.5%€99k▲ 7.9%
Operating result€28k-€50k▲ 74.9%€44k▼ 12.0%€14k▼ 69.0%
Net result€20k-€36k▲ 86.4%€31k▼ 15.4%€7k▼ 76.6%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result has fallen two years in a row; 2025 is 69% below 2024 and is the lowest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €219k
Fixed assets
€190k ▼ 19.0%
Current assets
€29k ▼ 30.4%
Equity and liabilities €219k
Equity
€99k ▲ 7.9%
Debt
€120k ▼ 34.9%
Debt's share of the balance-sheet total falls from 66.7% to 54.7%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€58k▼
2024 · €88k
Cash flow
€52k▼
2024 · €75k
Current ratio
0.52▼
2024 · 0.53
Debt to equity
1.21▼
2024 · 2.00
ROE
7.3%▼
2024 · 33.6%
ROA
3.3%▼
2024 · 11.2%
Interest coverage
18.63▼
2024 · 21.88
Debt ≤ 1 year
€55k▼
2024 · €77k
Debt > 1 year
€64k▼
2024 · €107k
Income taxes
€3k▼
2024 · €9k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 38 lines
Balance sheet
Code20242025
Assets
Total assets20/58€276k€219k▼
Fixed assets21/28€235k€190k▼
Intangible fixed assets21€206k€165k▼
Tangible fixed assets22/27€29k€25k▼
Plant, machinery and equipment23€29k€25k▼
Current assets29/58€41k€29k▼
Amounts receivable within one year40/41-€6k
Other amounts receivable41-€6k
Cash at bank and in hand54/58€38k€21k▼
Deferred charges and accrued income490/1€3k€2k▼
Equity and liabilities
Total equity and liabilities10/49€276k€219k▼
Equity10/15€92k€99k▲
Contributions10/11€5k€5k=
Profit (loss) carried forward14€87k€94k▲
Amounts payable17/49€184k€120k▼
Amounts payable after more than one year17€107k€64k▼
Financial debts170/4€107k€64k▼
Amounts payable within one year42/48€77k€55k▼
Current portion of amounts payable after more than one year42€42k€43k▲
Trade debts44€2k€3k▲
Suppliers440/4€2k€3k▲
Taxes, remuneration and social security45€10k€10k=
Taxes450/3€10k€10k=
Other amounts payable47/48€24k-
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€45k€45k=
Other operating charges640/8€617€633▲
Gross operating margin9900€89k€59k▼
Operating profit (loss)9901€44k€14k▼
Financial income75/76B-€0
Recurring financial income75-€0
Financial charges65/66B€4k€3k▼
Recurring financial charges65€4k€3k▼
Profit (loss) for the period before taxes9903€40k€10k▼
Income taxes67/77€9k€3k▼
Profit (loss) for the period9904€31k€7k▼
Profit (loss) for the period to be appropriated9905€31k€7k▼
Appropriation of the result
Profit (loss) to be appropriated9906€87k€94k▲
Profit (loss) brought forward from the previous period14P€56k€87k▲
The notes to these accounts (8 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
03-07
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial
Weakest financial yearnet €7k ▼76.6%
Net result drops to €7k, the lowest in the series.
30-06
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
16-07
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial
Highest result since 2022net €36k ▲86.4%
Operating result €50k, net result €36k, both a record.
20-07
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Soignies · 1 establishment unit since 2022
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Rue de Sirieu 2997061 SoigniesGround area
950 m²
Building footprint
90 m²
Volume, LiDAR
759 m³
Parcel 55044B0045/00P000, Wallonia · tallest building 10.0 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
SRL Docteur Renaux Delphine
since 20222.327.596.360
1 parcel
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 55044B0045/00P000 | Wallonia | 950 m² | 1 · 90 m² | 9.9 m · 3 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded23-12-2021
Fiscal year end31-12
Sources
Crossroads Bank for EnterprisesNational Bank · 4 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.
Contact details
3 entriesE-mail:delphine.renaux@hotmail.com
Phone:+32483618430
Phone:0483618430